News from the healthcare data industry
Findings support deep learning ex vivo drug screening with patient tissue as a promising tool to identify effective, individual treatments in advanced blood cancer over conventional methods Custom deep learning...
TEL AVIV, Israel, Feb. 10, 2022 /PRNewswire/ —CytoReason, a leading developer of computational disease models for efficient drug discovery and development, today announced the extension of its collaboration agreement with Pfizer. “The...
Abiomed Inc., has worked the ventricular assist device (VAD) space for a number of years with its Impella series of VADs, and a study coming out of Japan seems to...
September 20, 2022 08:00 AM Eastern Daylight Time LOUISVILLE, Colo. & ASHEVILLE, N.C.–(BUSINESS WIRE)–Trio Health (Trio), a leading provider of real-time data on real-world patients, and Allergy Partners, the nation’s...
SAN FRANCISCO, Sept. 19, 2022 /PRNewswire/ — Verana Health®—a digital health company elevating quality in real-world data—will present an abstract at the American Statistical Association’s (ASA) Biopharmaceutical Section Regulatory-Industry Statistics Workshop on Sept. 21 in Rockville,...
Abstract The combination of medication containing elexacaftor, ivacaftor, and tezacaftor (EIT) has dramatically impacted the treatment and prognosis for patients with cystic fibrosis (CF). Lung function, weight, and self-reported quality...
A survey of life sciences leaders reveals some of the key challenges thatcome with using real-world data (RWD) for innovation, along with theirvision and predictions for how RWD can accelerate...
For a long time, doctors’ offices, large or small, operated under a seeming contradiction; even as modern medicine pushed the frontiers of innovation, providing new treatments and sometimes cures for...
BOSTON, Sept. 15, 2022 /PRNewswire/ — Arcadia, the leading data analytics platform for healthcare, today announced it has partnered with Snowflake, the Data Cloud company, to make Arcadia’s de-identified electronic health record (EHR) and...
SAN FRANCISCO and NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...